Literature DB >> 8708165

Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia.

H M Oudemans-van Straaten1, P G Jansen, H te Velthuis, I C Beenakkers, C P Stoutenbeek, S J van Deventer, A Sturk, L Eysman, C R Wildevuur.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the increase in post-operative oxygen consumption (delta VO2) in cardiac surgery patients is related to endotoxemia and subsequent cytokine release and whether delta VO2 can be used as a parameter of post-perfusion syndrome.
DESIGN: Prospective study.
SETTING: Operating room and intensive care unit of a university hospital. PATIENTS: Twenty-one consecutive male patients undergoing elective coronary artery bypass surgery without major organ dysfunction and not receiving corticosteroids. MEASUREMENTS AND
RESULTS: Plasma levels of endotoxin, tumor necrosis factor (TNF) and interleukin-6 (IL-6) were measured before, during and for 18 h after cardiac surgery. Oxygen consumption, haemodynamics, the use of IV fluids and dopamine, body temperature and the time of extubation were also measured. Measurements from patients with high delta VO2 (> or = median value of the entire group) were compared with measurements from patients with low delta VO2 (< median). Patients with high delta VO2 had higher levels of circulating endotoxin (P = 0.004), TNF (P = 0.04) and IL-6 (P = 0.009) received more IV fluids and dopamine while in the ICU, and were extubated later than patients with low delta VO2. Several hours after delta VO2 the patient's body temperature rose. Forward stepwise regression analysis showed that circulating endotoxin and TNF explained 50% of the variability of delta VO2.
CONCLUSIONS: This study demonstrates that patients with high post operative oxygen consumption after elective cardiac surgery have higher circulating levels of endotoxin, TNF and IL-6 and also have more symptoms of post-perfusion syndrome. Early detection of high VO2 might be used as a clinical signal to improve circulation in order to meet the high oxygen demand of inflammation. In addition, continuous measurement of VO2 provides us with a clinical parameter of inflammation in interventional studies aiming at a reduction of endotoxemia or circulating cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708165     DOI: 10.1007/BF01700449

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans.

Authors:  A F Suffredini; J H Shelhamer; R D Neumann; M Brenner; R J Baltaro; J E Parrillo
Journal:  Am Rev Respir Dis       Date:  1992-06

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

3.  Perfusion-related factors of endotoxin release during cardiopulmonary bypass.

Authors:  P G Jansen; H Te Velthuis; H M Oudemans-Van Straaten; E R Bulder; S J Van Deventer; A Sturk; L Eijsman; C R Wildevuur
Journal:  Eur J Cardiothorac Surg       Date:  1994       Impact factor: 4.191

4.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.

Authors:  D E Chenoweth; S W Cooper; T E Hugli; R W Stewart; E H Blackstone; J W Kirklin
Journal:  N Engl J Med       Date:  1981-02-26       Impact factor: 91.245

5.  The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.

Authors:  Y M Fong; M A Marano; L L Moldawer; H Wei; S E Calvano; J S Kenney; A C Allison; A Cerami; G T Shires; S F Lowry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality.

Authors:  M R Pinsky; J L Vincent; J Deviere; M Alegre; R J Kahn; E Dupont
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

7.  Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings.

Authors:  H R Michie; D R Spriggs; K R Manogue; M L Sherman; A Revhaug; S T O'Dwyer; K Arthur; C A Dinarello; A Cerami; S M Wolff
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

8.  Intestinal ischemia and shock factors.

Authors:  U Haglund; O Lundgren
Journal:  Fed Proc       Date:  1978-11

9.  Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass.

Authors:  N J Jansen; W van Oeveren; Y J Gu; M H van Vliet; L Eijsman; C R Wildevuur
Journal:  Ann Thorac Surg       Date:  1992-10       Impact factor: 4.330

10.  Endotoxemia associated with cardiopulmonary bypass.

Authors:  D A Rocke; S L Gaffin; M T Wells; Y Koen; J G Brock-Utine
Journal:  J Thorac Cardiovasc Surg       Date:  1987-06       Impact factor: 5.209

View more
  6 in total

1.  Resting energy expenditure after Fontan surgery in children with single-ventricle heart defects.

Authors:  Nilesh M Mehta; John M Costello; Lori J Bechard; Victor M Johnson; David Zurakowski; Francis X McGowan; Peter C Laussen; Christopher P Duggan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2012-04-26       Impact factor: 4.016

2.  Analysis of P50 and oxygen transport in patients after cardiac surgery.

Authors:  H M Oudemans-van Straaten; G J Scheffer; C P Stoutenbeek
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

3.  Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Role of type of flow and protective effect of selective digestive decontamination.

Authors:  A E Martinez-Pellús; P Merino; M Bru; J Canovas; G Seller; J Sapiña; T Fuentes; J Moro
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

Review 4.  Systemic oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure-an interim review.

Authors:  Jia Li
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-28

5.  Effects of cardiopulmonary bypass on tight junction protein expressions in intestinal mucosa of rats.

Authors:  Ying-Jie Sun; Wei-Min Chen; Tie-Zheng Zhang; Hui-Juan Cao; Jin Zhou
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

6.  Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts).

Authors:  M Loebe; S Locziewski; F M Brunkhorst; C Harke; R Hetzer
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.